Resources

Content Download: Formulation Development Packages for PLA/PLGA Nanoparticles

Form

Fill Out The Form To Begin Your Download

Curapath introduces a structured suite of Formulation Development Packages, designed to streamline the creation and optimization of PLA/PLGA-based nanoparticles for the encapsulation of peptides and small molecules.

Package Highlights:

Essential: Rapid development of PLA/PLGA + API nanoparticles, adapted to scalable manufacturing.

Advanced: Enhanced targeting.
Expert: Full analytical depth with functionalized PLGAs and in vitro studies.
PLGA Nanoparticle Formulation

These packages offer increasing levels of formulation complexity, analytical depth, and customization, supporting scalable development from early-stage screening to preclinical readiness. Each tier includes access to proprietary methods and materials, including shielding lipids, targeted PLGA variants, and functionalized H-terminated PLGAs, enabling the design of high-performance, non-viral delivery systems.

Discover how our customizable, cost-effective solutions can accelerate your nanoparticle development.

 

Lipid-Nanopeptide_0
Support for Your Therapeutic Program

Contact a Chemist Today

Contact Us, and we can discuss your specific therapeutic program and how Curapath can help build the right solution to advance your unique drug.